找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Immunosuppression under Trial; Proceedings of the 3 P. Cochat,J. Traeger,M. Derchavane Conference proceedings 1999 Springer Science+Busines

[復(fù)制鏈接]
查看: 12349|回復(fù): 55
樓主
發(fā)表于 2025-3-21 16:55:48 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Immunosuppression under Trial
副標(biāo)題Proceedings of the 3
編輯P. Cochat,J. Traeger,M. Derchavane
視頻videohttp://file.papertrans.cn/463/462291/462291.mp4
叢書名稱Transplantation and Clinical Immunology
圖書封面Titlebook: Immunosuppression under Trial; Proceedings of the 3 P. Cochat,J. Traeger,M. Derchavane Conference proceedings 1999 Springer Science+Busines
描述Immunosuppression in solid organ transplantation is currentlyexperiencing a worldwide revival since new drugs are now available andothers are under development. In order to contribute to the design offuture strategies, a critical approach of surrogate endpoints is givenand long-term side effects are analysed, together with the impact ofnon-compliance, quality-of-life and economical parameters. In thisbook, international specialists have set up the scientific rationaleand provided new bases for further immunosuppressive strategies.
出版日期Conference proceedings 1999
關(guān)鍵詞cancer; clinical trial; immunosuppression; kidney; transplantation
版次1
doihttps://doi.org/10.1007/978-94-011-4643-2
isbn_softcover978-94-010-5960-2
isbn_ebook978-94-011-4643-2
copyrightSpringer Science+Business Media Dordrecht 1999
The information of publication is updating

書目名稱Immunosuppression under Trial影響因子(影響力)




書目名稱Immunosuppression under Trial影響因子(影響力)學(xué)科排名




書目名稱Immunosuppression under Trial網(wǎng)絡(luò)公開度




書目名稱Immunosuppression under Trial網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Immunosuppression under Trial被引頻次




書目名稱Immunosuppression under Trial被引頻次學(xué)科排名




書目名稱Immunosuppression under Trial年度引用




書目名稱Immunosuppression under Trial年度引用學(xué)科排名




書目名稱Immunosuppression under Trial讀者反饋




書目名稱Immunosuppression under Trial讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 22:31:27 | 只看該作者
板凳
發(fā)表于 2025-3-22 01:28:08 | 只看該作者
Minimal standards for reporting clinical trial results in transplantationbenefit of that therapy. Not all therapeutic decisions in medicine are based on the results of clinical trials. For example, insulin is the standard treatment of diabetic ketoacidosis, even though this therapy was never tested in a randomized controlled trial. Similarly, the need to use immunosuppre
地板
發(fā)表于 2025-3-22 06:42:42 | 只看該作者
5#
發(fā)表于 2025-3-22 09:33:29 | 只看該作者
6#
發(fā)表于 2025-3-22 13:18:48 | 只看該作者
7#
發(fā)表于 2025-3-22 17:50:43 | 只看該作者
Factors influencing long-term allograft survival the steady attrition of transplanted organs due to chronic rejection. The UNOS published half-life for cadaveric renal allografts is approximately 8.5 years, not significantly different from the 7.7 year half-life published for cadaveric renal allografts under azathioprine-prednisone immunosuppress
8#
發(fā)表于 2025-3-22 23:40:26 | 只看該作者
9#
發(fā)表于 2025-3-23 04:57:48 | 只看該作者
Cardiovascular complications after renal transplantation than 49.2% by death with a functioning graft, while other causes account for a further 9.4%. Thus, reduction of cardiovascular death will be a very efficient measure to preserve grafts. According to the EDTA Registry [2], the frequency of death from cardiovascular causes increases markedly with age
10#
發(fā)表于 2025-3-23 06:28:36 | 只看該作者
Strategies to minimize nephrotoxicity associated to calcineurin inhibitorsclosporine and tacrolimus has been reported [1–3]. Mihatsch et al. [4] found that the side effect pattern of these drugs is nearly identical: they were unable to differentiate morphological changes associated with their clinical nephrotoxicity.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-19 22:01
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
大同县| 鄂托克前旗| 泌阳县| 剑河县| 安乡县| 江津市| 合山市| 盐亭县| 朝阳市| 班玛县| 广河县| 定远县| 万山特区| 虹口区| 泉州市| 惠水县| 沾益县| 金平| 河北省| 峡江县| 兴文县| 长汀县| 泸州市| 临夏县| 民和| 塔河县| 肇庆市| 九寨沟县| 长汀县| 江山市| 长武县| 迁西县| 武乡县| 仙居县| 澄迈县| 长寿区| 辽阳县| 亚东县| 兰坪| 紫云| 岫岩|